扫描下面的二维码:
"热点聚焦"标签列表
What Do We Know about the Difficult-to-Treat Patient with Chronic Hepatitis C Infection ?2009-02-14
Strengthening Investigation on the Role of HBV Resistance Monitoring2009-02-14
Is There any Loophole in the Roadmap Model?2009-02-14
New Insights into HBV Genotypes and HCC2009-02-14
Assessment of Nonalcoholic Fatty Liver Disease2009-02-14
Latest Study on Targeted Therapy for HCC2009-02-14
Comment on the Controversy in Guidelines of HBV Concurrent2009-02-14
The Most Recent Progression of Ascites and SBP2009-02-14
Emphasizing the Significance of the Role of HBV DNA Monitoring2009-02-14
Nucleos(t)ide Analogs Can Be Stopped - PRO2009-02-14
Strengthening Investigation on the Role of HCV RNA Monitoring2009-02-14
Tenofovir in HBV treatment2009-02-14
easily be higher when long-term therapy is needed.2009-02-14
Current Situation of the Epidemiology of HCC in Asia Pacific2009-02-14
急性肝衰竭2009-02-14
慢性乙型肝炎的治疗—2009年及未来2009-02-14
核苷(酸)类似物治疗可以停止2009-02-14
丙肝治疗中HCV基因型及改善生活方式2009-02-14
HCV感染的基因治疗2009-02-14
替诺福韦酯治疗慢性乙型肝炎2009-02-14